Literature DB >> 17135276

APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.

Andrew Latchford1, Emmanouil Volikos, Victoria Johnson, Pauline Rogers, Nirosha Suraweera, Ian Tomlinson, Robin Phillips, Andrew Silver.   

Abstract

Analysis of APC mutations in colonic and duodenal tumours from familial adenomatous polyposis (FAP) patients has shown that the site of the first hit, the germline mutation, can predict the type and position of the somatic mutation or 'second hit'. The two APC mutations are selected on the basis of a 'just right' level of beta-catenin signalling in intestinal tumours achieved through retention of some of the seven 20-amino-acid beta-catenin degradation repeats. Desmoids are a life threatening extra-colonic manifestation in FAP patients. These aggressive tumours of mesenchymal origin are, at present, poorly characterized in terms of mutational APC spectra. We have investigated somatic mutations in the largest cohort of FAP-associated desmoids to date, and combined our results with previously published data. Somatic mutations were found to occur non-randomly and the position of the germline mutation shown to be a major determinant of the somatic mutation, a characteristic shared with intestinal tumours from FAP patients. In contrast to colonic polyps, loss of heterozygosity in desmoids involved deletion rather than mitotic recombination. While tumours from the colorectum and upper gastrointestinal tract usually retain one to two and three to four beta-catenin degradation repeats, respectively, most desmoids preferentially retain two repeats (P < 0.001, chi2 test). In addition, most desmoids with two APC hits (87%, 26/30) had one mutated allele with no 20-amino acid repeats (P < 0.001). This feature, unique among FAP tumours, indicates that a mutation deleting all repeats from one allele may be an important component in maintaining appropriate levels of beta-catenin signalling levels in desmoid tumour cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17135276     DOI: 10.1093/hmg/ddl442

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Tomonori Ohsawa; Keiichiro Ishibashi; Mineko Ushiama; Teruhiko Yoshida; Takeo Iwama
Journal:  Oncol Lett       Date:  2015-08-06       Impact factor: 2.967

2.  Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Authors:  Adelaide M Carothers; Hira Rizvi; Rian M Hasson; Yvonne I Heit; Jennifer S Davids; Monica M Bertagnolli; Nancy L Cho
Journal:  Cancer Res       Date:  2011-11-17       Impact factor: 12.701

3.  Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients.

Authors:  Sai Ge; Duo Cheng; Xuhui Zhang; Ting Xu; Zhenghang Wang; Fengxiao Dong; Lan Su; Jinlei Song; Jia Wang; Jian Li; Lin Shen; Xicheng Wang
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

4.  CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.

Authors:  Thomas Naert; Dieter Tulkens; Tom Van Nieuwenhuysen; Joanna Przybyl; Suzan Demuynck; Matt van de Rijn; Mushriq Al-Jazrawe; Benjamin A Alman; Paul J Coucke; Kim De Leeneer; Christian Vanhove; Savvas N Savvides; David Creytens; Kris Vleminckx
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 12.779

5.  Identification of 5 novel germline APC mutations and characterization of clinical phenotypes in Japanese patients with classical and attenuated familial adenomatous polyposis.

Authors:  Hong Tao; Kazuya Shinmura; Hidetaka Yamada; Masato Maekawa; Satoshi Osawa; Yasuhiro Takayanagi; Kazuya Okamoto; Tomohiro Terai; Hiroki Mori; Toshio Nakamura; Haruhiko Sugimura
Journal:  BMC Res Notes       Date:  2010-11-16

Review 6.  Genes associated with Parkinson syndrome.

Authors:  Saskia Biskup; Manfred Gerlach; Andreas Kupsch; Heinz Reichmann; Peter Riederer; Peter Vieregge; Ullrich Wüllner; Thomas Gasser
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

7.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Authors:  Alexander J F Lazar; Daniel Tuvin; Shohrae Hajibashi; Sultan Habeeb; Svetlana Bolshakov; Empar Mayordomo-Aranda; Carla L Warneke; Dolores Lopez-Terrada; Raphael E Pollock; Dina Lev
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  Familial adenomatous polyposis-associated desmoids display significantly more genetic changes than sporadic desmoids.

Authors:  Els Robanus-Maandag; Cathy Bosch; Saeid Amini-Nik; Jeroen Knijnenburg; Karoly Szuhai; Pascale Cervera; Raymond Poon; Diana Eccles; Paolo Radice; Marco Giovannini; Benjamin A Alman; Sabine Tejpar; Peter Devilee; Riccardo Fodde
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

9.  Extra-abdominal desmoid tumors associated with familial adenomatous polyposis.

Authors:  George T Calvert; Michael J Monument; Randall W Burt; Kevin B Jones; R Lor Randall
Journal:  Sarcoma       Date:  2012-06-03

10.  Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.

Authors:  Jean Schneikert; Shree Harsha Vijaya Chandra; Jan Gustav Ruppert; Suparna Ray; Eva Maria Wenzel; Jürgen Behrens
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.